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Engineered fusion proteins containing two or more func-
tional polypeptides joined by a peptide or protein linker
are important for many fields of biological research. The
separation distance between functional units can impact
epitope access and the ability to bind with avidity; thus the
availability of a variety of linkers with different lengths
and degrees of rigidity would be valuable for protein
design efforts. Here, we report a series of designed struc-
tured protein linkers incorporating naturally occurring
protein domains and compare their properties to commonly
used Gly4Ser repeat linkers. When incorporated into the
hinge region of an immunoglobulin G (IgG) molecule, flex-
ible Gly4Ser repeats did not result in detectable extensions
of the IgG antigen-binding domains, in contrast to linkers
including more rigid domains such as b2-microglobulin,
Zn-a2-glycoprotein and tetratricopeptide repeats. This
study adds an additional set of linkers with varying lengths
and rigidities to the available linker repertoire, which may
be useful for the construction of antibodies with enhanced
binding properties or other fusion proteins.
Keywords: fusion proteins/hydrodynamic radius/linker
design/size-exclusion chromatography
Introduction
Fusion proteins are engineered biomolecules containing parts
from two or more genes synthesized as a single multi-
functional construct. These have been critical in many areas of
biological research including affinity purification (Lichty
et al., 2005) and protein stabilization for structure determin-
ation (Zou et al., 2012). Bi-specific fusion proteins have also
been utilized as biopharmaceuticals, with an active drug
domain fused to a carrier domain, allowing for the drug’s
proper transport (Chen et al., 2013). Such proteins have been
designed to penetrate epithelial membranes including the
blood–brain barrier, as well as to target a specific cell popula-
tion (Pardridge, 2010). Due to the modularity of protein
domains in the generation of functional constructs, fusion
proteins will likely have increasing importance in research and
drug design.
The successful construction of fusion proteins relies on the
proper choice of a protein linker as direct fusion of two
domains can lead to compromised biological activity (Bai
et al., 2005; Zhang et al., 2009). Several studies have utilized
existing databases to compile and characterize linkers in natur-
ally occurring multi-domain proteins (Argos, 1990; George
and Heringa, 2002). These studies have yielded amino acid
sequence propensities for natural linkers of various sizes and
lengths, as well as information on rigidity and secondary struc-
ture. This information has helped the empirical design of
linkers that are customized for particular applications.
Linkers can be classified into three groups: flexible, rigid
and cleavable (Chen et al., 2013). Flexible linkers are generally
composed of small, non-polar or polar residues such as Gly,
Ser and Thr. The most common is the (Gly4Ser)n linker
(Gly–Gly–Gly–Gly–Ser)n, where n indicates the number of
repeats of the motif. Polyglycine linkers have also been evalu-
ated, but the addition of a polar residue such as serine can
reduce linker–protein interactions and preserve protein func-
tion. Due to their flexibility, these linkers are unstructured and
thus provided limited domain separation in a previous study
(Evers et al., 2006). As a result, more rigid linkers including
polyproline motifs (Schuler et al., 2005) and an all a-helical
linker A(EAAAK)nA (Arai et al., 2001) have been developed.
We are interested in using relatively rigid protein linkers to
separate anti-HIV binding proteins at distances that would
permit bi- or multi-valent binding to HIV Env glycoproteins
with the objective of creating reagents capable of cross-linking
epitopes within a single Env trimer (intra-spike cross-linking).
Such reagents would take advantage of avidity effects to minim-
ize HIV’s ability to evade neutralizing antibodies by rapidly
mutating to lower the affinity between the HIV epitopes and the
antigen recognition fragment (Fab) of the antibody (Klein et al.,
2009). Although the architecture of the HIV spike trimer does
not permit intra-spike cross-linking by most natural antibodies
(Zhu et al., 2006;Klein and Bjorkman, 2010), it may be possible
to create reagents capable of bivalent binding to an HIV Env
trimer by fusing two identical reagents or two different reagents
with an appropriate length linker. Here we report the design,
construction and characterization of a series of structured protein
linkers incorporating both rigid and flexible domains that can be
used to achieve a variety of different desired separations. The
linkers were incorporated into the hinge region of an intact
immunoglobulin G (IgG) antibody and evaluated for their rela-
tive lengths and rigidities by dynamic light scattering (DLS).
Methods
Plasmid construction and protein purification
Genes encoding designed linkers were synthesized (Blue
Heron Bio) with restriction sites for the enzymes NheI
(50-end) and either NgoMIV or HindIII (30-end). These sites†These authors contributed equally to this work.
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were also introduced into the gene encoding the heavy chain
of the HIV-neutralizing antibody b12 (Roben et al., 1994)
such that the insert would be located between hinge region
residues His235 and Thr236. Constructs encoding the b12
heavy chain gene with a linker inserted in the hinge region were
subcloned into the pTT5 mammalian expression vector. The
b12-linker IgGs were expressed transiently in HEK-6E cells by
co-transfecting the b12-linker heavy chain genes with the b12
light chain gene as described (Diskin et al., 2011).
IgG-linker fusion constructs were purified by protein A
affinity chromatography (GE Healthcare) followed by purifica-
tion and analysis by size-exclusion chromatography (SEC)
using a Superdex 200 10/300 GL column (GE Healthcare) in
phosphate-buffered saline, 0.05% w/v sodium azide, pH 7.4.
Dynamic light scattering
Fractions corresponding to the center of the SEC elution peak
were concentrated using Amicon Ultra-15 Centrifugal Filter
Units (Millipore) with a molecular weight cutoff of 100 kDa
to a volume of 80–400 ml and concentrations of 0.5–1 mg/ml.
Concentration differences within this range were not observed
to affect the hydrodynamic radius values determined by DLS
(data not shown). Sample sizes ranging from 80 to 350 ml
were loaded into a disposable cuvette, and measurements were
performed on a DynaProw NanoStarTM (Wyatt Technology)
using manufacturer’s suggested settings. A fit of the second-
order autocorrelation function to a globular protein model was
used to derive the hydrodynamic radius.
Results and discussion
Design and identity of designed linkers
In order to design potential structured linkers, we surveyed the
Protein Data Bank (PDB) to find structures that were relatively
elongated and rigid, or represented small globular proteins.
We chose Zn-a2-glycoprotein (ZAG; PDB code: 1ZAG) as an
example of a relatively elongated and rigid structure (Sanchez
et al., 1999), and b2-microgloblin (b2m; PDB code: 1LDS)
and ubiquitin (Ub; PDB code: 1UBQ) as examples of small
globular proteins (Fig. 1A). ZAG is a 31.5 kDa protein with a
class I major histocompatibility complex heavy chain-like fold
and a separation distance between the N- and C-termini of
45 A˚. b2m is a stable 12 kDa protein with an immuno-
globulin constant region-like fold that forms a rigid structure
with a separation distance between the N- and C-terminus of
35 A˚ (Trinh et al., 2002). Likewise, Ub is a compact, stable
8.5 kDa protein with an N- and C-terminal separation distance
of 37 A˚ (Vijay-Kumar et al., 1987). In addition to the struc-
tured linkers chosen from the PDB, proline-rich linkers were
designed from the hinge sequence from IgA1 (polyPro and
polyPro(Glyc)). This glycosylated region confers rotational flexi-
bility of the Fab relative to the Fc in the context of wild-type
dimeric IgA1 (Bonner et al., 2008). In addition, glycosylation
has been shown to potentially increase stability of polypeptide
linkers (Imperiali and O’Connor, 1999). ZAG, b2m and Ub
proteins were joined in various combinations with short linker
regions, either (Gly2Ser)n repeats, glycosylated proline-rich
sequences (polypro(Glyc), or unglycosylated proline-rich
sequences (polypro), to create linkers L1–L12 (Table I).
We also created linkers using tetratricopeptide repeat
domains (TPRs; PDB code: 2AVP; L13–L16; Table I; Fig. 1A)
(Kajander et al., 2007) that are found in natural proteins such
as HSP70/90 (Scheufler et al., 2000). These domains are
optimal for use as potential structured linkers because the
length of a set of tandem TPR domains corresponds predict-
ably with the number of repeats. Each repeat consists of
34 amino acids with a defined sequence motif that forms two
a-helices (D’Andrea and Regan, 2003). Seven to eight TPRs
Fig. 1. (A) Schematic of wild-type IgG (left) and IgG with a designed linker in its hinge region (middle). IgG domains are color coded as shown in the right panel.
(B) Ribbon diagrams for domains used in structured linkers shown to scale (pdb codes: ZAG (1ZAG), b2m (1LDS), cTPR (2FO7), ubiquitin (1UBQ)). The cTPR
structure shown contains eight tandem repeats. N- and C-terminal residues are shown as sticks, color-coded blue for the N-terminus and red for the C-terminus.
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form a complete superhelical turn with a pitch of 72 A˚. For
our TPR linkers, we used a consensus sequence defined by
the amino acid of the greatest global propensity in the natural
database of the TPR domains at each position, which was
shown to form a stable superhelix and was therefore named
the consensus TPR sequence or cTPR (Main et al., 2003).
Finally, for comparison, we constructed a series of
(Gly4Ser)n linkers (L17–L24; Table I) in order to determine
the effect of increasing the number of flexible Gly4Ser repeats
on the hydrodynamic radius of the IgG. The complete sequence
of each linker is given in Table II.
As a scaffold for comparing the designed structured linkers,
we inserted each into the hinge region of an intact IgG anti-
body (the anti-HIV antibody b12) (Roben et al., 1994). We
chose the hinge region of an IgG, which encompasses the
amino acids between the C-terminus of the heavy chain
portion of the antigen-binding fragment (Fab) and the
N-terminus of the Fc, to insert the linkers because it can toler-
ate large protein insertions (Redpath et al., 1998). In addition,
extension in the hinge region could potentially increase the
separation distance of the Fab arms (Fig. 1B).
Characterization of the IgGs containing structured linkers
The b12 IgG proteins containing linkers L1–L24 were
expressed by transient transfection in HEK 293-6E mammalian
cells and purified by affinity and size exclusion chromatography.
Visualization by sodium dodecyl sulfate–polyacrylamide gel
electrophoresis (SDS–PAGE) for IgGs containing the L1–L8
linkers showed that all proteins were purified to .95%
homogeneity (Fig. 2). Under reducing conditions, two heavy
chain bands were observed for b12-L1, which contained a linker
containing three potential N-linked glycosylation sites, indicat-
ing the presence of multiple glycosylated isoforms. An overlay
of the chromatograms derived from SEC showed that the IgGs
containing the L1–L8 structured linkers all exhibited a decrease
in retention volume relative to wild-type IgG, consistent with the
expected increases in the radius of gyration (Rg) of each of the
constructs due to the addition of a structured linker (Fig. 3).
We next derived the hydrodynamic radii using DLS for
wild-type b12 and the b12 proteins containing designed
linkers. DLS measures fluctuations in the intensity of scattered
light of a protein solution over time, which can be used to cal-
culate an autocorrelation function of intensity (Nobbmann
et al., 2007). Typical monodisperse samples (including our
hinge-linked antibodies) generate an exponential decay in the
autocorrelation. A least squares fit can be performed to calcu-
late the decay constant, which directly relates to the diffusion
coefficient. The diffusion coefficient is then inversely related
to the characteristic hydrodynamic radius RH, which reflects
the radius of a hypothetical solid sphere that would diffuse at
the same rate as the protein. The RH value is not a direct meas-
urement of the length that the linker contributes to the size of
the IgG. However, comparative analysis can yield rank order
differences for the relative lengths and rigidity of the various
linkers. For example, if the separation between the IgG Fc and
Fab domains were increased by the addition of a designed
hinge linker, we would expect an observable increase in the
RH of the fusion construct compared with the parental b12 IgG
due to increased size of the diffusion sphere.
The hydrodynamic radii were measured by DLS for each of
the b12 IgG-linker fusion proteins and compared with an
internal wild-type b12 IgG control (Fig. 4). By comparing
constructs containing elongated or small protein domain linkers,
cTPR repeat linkers and flexible (Gly4Ser)n linkers of various
lengths (L17–L24), we could directly compare the effects of
incorporating different lengths of flexible vs. structured proteins
linkers.
We observed a consistent trend for the RH values between
glycosylated and non-glycosylated linkers (L1, L2, L3 and L12
vs. L4). The incorporation of three potential N-linked glycosyla-
tion sites in proline-rich linkers derived from the hinge region of
IgA1 (L1) appeared to increase the RH relative to constructs con-
taining similar linker sequences with only one (L2) or no (L4)
N-linked glycosylation sites, possibly through stabilization of
the folded state and leading the linker to adopt a more extended
conformation (Shental-Bechor and Levy, 2008). While the add-
ition of only a single potential N-linked glycosylation site did
not seem to affect the diffusion rate of proline-rich linkers
(compare L2 and L4), a single potential N-linked glycosylation
in the GGSG-NSS-GSGG region of a combination proline-rich
and Gly2Ser linker (L3) increased its RH beyond the RH of a
proline-rich linker with three potential N-linked glycosylation
sites (L1). These data are consistent with the observation that
N-linked glycosylation confers rigidity in the backbone of a flex-
ible linker (Liu et al., 2000), suggesting these reagents contained
linkers with a more extended conformation. Thus incorporating
potential N-linked glycosylation sites within flexible linkers
may be a general method to increase linker rigidity.
Adding a single b2m domain to a linker increased the RH of
the b12-linker protein to a similar degree as a proline-rich
repeat relative to IgG (compare L5 to L2, L4 and IgG),
Table I. Description of structured linker designs
Linker Name Description
L1 GPcPcPc GlySer-polyPro(Glyc)-polyPro(Glyc)-polyPro(Glyc)
L2 GPPcP GlySer-polyPro-polyPro(Glyc)-polyPro
L3 GPGcP GlySer-polyPro-GlySer(Glyc)-polyPro
L4 GPPP GlySer-polyPro-polyPro-polyPro
L5 GPbP GlySer-polyPro-b2m-polyPro
L6 GPbG GlySer-polyPro-b2m-GlySer
L7 PbGbG polyPro-b2m-GlySer-b2m-GlySer
L8 GPbGbP GlySer-polyPro-b2m-GlySer-b2m-polyPro
L9 GPUG GlySer-polyPro-Ub-GlySer
L10 GPZP GlySer-polyPro-ZAG-polyPro
L11 GGZGZP GlySer-GlySer-ZAG-GlySer-ZAG-polyPro
L12 GcGcP GlySer(Glyc)-GlySer(Glyc)-polyPro
L13 cTPR3 (G4S)3-cTPR3-(G4S)3
L14 cTPR6 (G4S)3-cTPR6-(G4S)3
L15 cTPR9 (G4S)3-cTPR9-(G4S)3
L16 cTPR12 (G4S)3-cTPR12-(G4S)3
L17 GS1 (G4S)1
L18 GS2 (G4S)2
L19 GS3 (G4S)3
L20 GS5 (G4S)5
L21 GS6 (G4S)6
L22 GS7 (G4S)7
L23 GS8 (G4S)8
L24 GS9 (G4S)9
(Gly4Ser)n, Gly–Gly–Gly–Gly–Ser sequence with n number of repeats;
GlySer, (N-term: AGS(GGS)3; Middle: (GGS)4; C-term: (GGS)3GAS]2S);
GlySer(Glyc), Gly–Gly–Ser sequence with an embedded potential N-linked
glycosylation site (Asn–Ser–Ser); polyPro, proline-rich hinge sequence from
IgA1; polyPro(Glyc), proline-rich hinge sequence from IgA1 with an
embedded potential N-linked glycosylation site (Asn–Ser–Ser); b2m,
b2-microglobulin; Ub, ubiquitin; ZAG, Zn-a2-glycoprotein; cTPRX,
consensus tetratricopeptide repeat sequence with X number of repeats.
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Table II. Complete sequences of designed linkers
Linker Name Complete sequence
L1 GPcPcPc AGSGGSGGSGGSPVPSTPPTNSSSTPPTPSPSPVPSTPPTNSSSTPPTPSPSPVPSTPPTNSSSTPPTPSPSAS
L2 GPPcP AGSGGSGGSGGSPVPSTPPTPSPSTPPTPSPSPVPSTPPTNSSSTPPTPSPSPVPSTPPTPSPSTPPTPSPSAS
L3 GPGcP AGSGGSGGSGGSPVPSTPPTPSPSTPPTPSPSGGSGNSSGSGGSPVPSTPPTPSPSTPPTPSPSAS
L4 GPPP AGSGGSGGSGGSPVPSTPPTPSPSTPPTPSPSPVPSTPPTPSPSTPPTPSPSPVPSTPPTPSPSTPPTPSPSAS
L5 GPbP AGSGGSGGSGGSPVPSTPPTPSPSTPPTPSPSIQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSK
DWSFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKWDRDPVPSTPPTPSPSTPPTPSPSAS
L6 GPbG AGSGGSGGSGGSPVPSTPPTPSPSTPPTPSPSIQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFS
KDWSFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKWDRDGGSGGSGGSGGSAS
L7 PbGbG AGPVPSTPPTPSPSTPPTPSPSIQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKDWSFYLLYY
TEFTPTEKDEYACRVNHVTLSQPKIVKWDRDGGSGGSGGSGGSIQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNG
ERIEKVEHSDLSFSKDWSFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKWDRDGGSGGSGGSGAS
L8 GPbGbP AGSGGSGGSGGSPVPSTPPTPSPSTPPTPSPSIQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSK
DWSFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKWDRDGGSGGSGGSGGSIQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSD
IEVDLLKNGERIEKVEHSDLSFSKDWSFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKWDRDPVPSTPPTPSPSTPPTPSPSAS
L9 GPUG AGSGGSGGSGGSPVPSTPPTPSPSTPPTPSPSQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDY
NIQKESTLHLVLRLRGGGGSGGSGGSGGSAS
L10 GPZP AGSGGSGGSGGSPVPSTPPTPSPSTPPTPSPSDGRYSLTYIYTGLSKHVEDVPAFQALGSLNDLQFFRYNSKDRKSQPMGLWRQVE
GMEDWKQDSQLQKAREDIFMETLKDIVEYYNDSNGSHVLQGRFGCEIENNRSSGAFWKYYYDGKDYIEFNKEIPAWVPFDPAAQIT
KQKWEAEPVYVQRAKAYLEEECPATLRKYLKYSKNILDRQDPPSVVVTSHQAPGEKKKLKCLAYDFYPGKIDVHWTRAGEVQE
PELRGDVLHNGNGTYQSWVVVAVPPQDTAPYSCHVQHSSLAQPLVVPWEASPVPSTPPTPSPSTPPTPSAS
L11 GGZGZP AGSGGSGGSGGSGGSGGSGGSGGSDGRYSLTYIYTGLSKHVEDVPAFQALGSLNDLQFFRYNSKDRKSQPMGLWRQVEGMEDW
KQDSQLQKAREDIFMETLKDIVEYYNDSNGSHVLQGRFGCEIENNRSSGAFWKYYYDGKDYIEFNKEIPAWVPFDPAAQITKQKW
EAEPVYVQRAKAYLEEECPATLRKYLKYSKNILDRQDPPSVVVTSHQAPGEKKKLKCLAYDFYPGKIDVHWTRAGEVQEPELRGD
VLHNGNGTYQSWVVVAVPPQDTAPYSCHVQHSSLAQPLVVPWEASGGSGGSGGSGGSDGRYSLTYIYTGLSKHVEDVPAFQALG
SLNDLQFFRYNSKDRKSQPMGLWRQVEGMEDWKQDSQLQKAREDIFMETLKDIVEYYNDSNGSHVLQGRFGCEIENNRSSGAFW
KYYYDGKDYIEFNKEIPAWVPFDPAAQITKQKWEAEPVYVQRAKAYLEEECPATLRKYLKYSKNILDRQDPPSVVVTSHQAPGEK
KKLKCLAYDFYPGKIDVHWTRAGEVQEPELRGDVLHNGNGTYQSWVVVAVPPQDTAPYSCHVQHSSLAQPLVVPWEASPVPSTP
PTPSPSTPPTPSPSAS
L12 GcGcP AGSGNSSGSGGSGGSGNSSGSGGSPVPSTPPTPSPSTPPTPSPSAS
L13 cTPR3 KLSGGGGSGGGGSGGGGSAEAWYNLGNAYYKQGDYQKAIEYYQKALELDPNNAEAWYNLGNAYYKQGDYQKAIEYYQKALEL
DPNNAEAWYNLGNAYYKQGDYQKAIEDYQKALELDPNNLQRSAGGGGSGGGGSGGGGAS
L14 cTPR6 KLSGGGGSGGGGSGGGGSAEAWYNLGNAYYKQGDYQKAIEYYQKALELDPNNAEAWYNLGNAYYKQGDYQKAIEYYQKALE
LDPNNAEAWYNLGNAYYKQGDYQKAIEDYQKALELDPNNLQAEAWKNLGNAYYKQGDYQKAIEYYQKALELDPNNASAWYNL
GNAYYKQGDYQKAIEYYQKALELDPNNAKAWYRRGNAYYKQGDYQKAIEDYQKALELDPNNRSRSAGGGGSGGGGSGGGGAS
L15 cTPR9 KLSGGGGSGGGGSGGGGSAEAWYNLGNAYYKQGDYQKAIEYYQKALELDPNNAEAWYNLGNAYYKQGDYQKAIEYYQKALEL
DPNNAEAWYNLGNAYYKQGDYQKAIEDYQKALELDPNNLQAEAWKNLGNAYYKQGDYQKAIEYYQKALELDPNNASAWYNLG
NAYYKQGDYQKAIEYYQKALELDPNNAKAWYRRGNAYYKQGDYQKAIEDYQKALELDPNNRSAEAWYNLGNAYYKQGDYQK
AIEYYQKALELDPNNAEAWYNLGNAYYKQGDYQKAIEYYQKALELDPNNAEAWYNLGNAYYKQGDYQKAIEDYQKALELDPN
NLQRSAGGGGSGGGGSGGGGAS
L16 cTPR12 KLSGGGGSGGGGSGGGGSAEAWYNLGNAYYKQGDYQKAIEYYQKALELDPNNAEAWYNLGNAYYKQGDYQKAIEYYQKALEL
DPNNAEAWYNLGNAYYKQGDYQKAIEDYQKALELDPNNLQAEAWKNLGNAYYKQGDYQKAIEYYQKALELDPNNASAWYNLG
NAYYKQGDYQKAIEYYQKALELDPNNAKAWYRRGNAYYKQGDYQKAIEDYQKALELDPNNRSAEAWYNLGNAYYKQGDYQK
AIEYYQKALELDPNNAEAWYNLGNAYYKQGDYQKAIEYYQKALELDPNNAEAWYNLGNAYYKQGDYQKAIEDYQKALELDPN
NLQAEAWKNLGNAYYKQGDYQKAIEYYQKALELDPNNASAWYNLGNAYYKQGDYQKAIEYYQKALELDPNNAKAWYRRGNAY
YKQGDYQKAIEDYQKALELDPNNRSAGGGGSGGGGSGGGGAS
L17 GS1 GGGGSAS
L18 GS2 GGGGSGGGGSAS
L19 GS3 GGGGSGGGGSGGGGSAS
L20 GS5 GGGGSGGGGSGGGGSGGGGSGGGGSAS
L21 GS6 GGGGSGGGGSGGGGSGGGGSGGGGSGGGGSAS
L22 GS7 AGGGSGGGGSGGGGSGGGGSGGGGSGGGGSGGGGSAS
L23 GS8 AGGGSGGGGSGGGGSGGGGSGGGGSGGGGSGGGGSGGGGSAS
L24 GS9 AGGGSGGGGSGGGGSGGGGSGGGGSGGGGSGGGGSGGGGSGGGGSAS
Linkers L1–L21 were inserted into the hinge region of b12 IgG between residues His235 and Thr236. Linkers L22–L24 were inserted into the same hinge
between residues Cys231 and Asp232.
Fig. 2. SDS–PAGE analysis of b12 IgG-structured linker proteins run under reducing (left) and non-reducing (right) conditions.
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suggesting that the structured b2m domain provided similar
bulk and separation to the polyPro repeat. However, adding a
second tandem b2m repeat separated from the first with a
(Gly2Ser)4 sequence did not increase the RH appreciably
(compare L8 and L5; L7 and L6). These results suggested that
coupling a flexible Gly–Ser linker with the rigid b2m domain
partially diminished the separation between Fc and Fab
regions provided by b2m alone. A similar observation was
made for hinge constructs containing ZAG (L10 and L11).
A linker containing ZAG alone increased the hydrodynamic
radius of the b12-linker protein compared with IgG and more
than the IgG–proline-rich linker (compare L10 to L2 and L4).
However, replacement of the proline-rich domain by ZAG that
was flanked at both termini by a (G2S)4 peptide resulted in a
decrease in hydrodynamic radius (compare L10 and L11).
We also investigated ubiquitin as a structured linker (L9).
However, initial characterization by SDS–PAGE showed deg-
radation at the linker site (data not shown). In addition, DLS
measurements revealed that a purified sample of b12-L9 had a
smaller RH than IgG similar to a Fab or Fc region alone,
further suggesting ubiquitin-specific degradation (Fig. 4).
cTPR linker series
cTPR constructs were generated with 3, 6, 9 or 12 tandem
repeats. All cTPR linkers were flanked by (Gly4Ser)3
sequences (Table II). The constructs exhibited a consistent
decrease in elution volume on SEC as a function of the repeat
length (Fig. 3). These constructs also predictably increased the
RH of the linked IgG with increased number of tandem repeats
(Fig. 4). The hydrodynamic radius of the cTPR12 construct
corresponded to approximately the size of L4, which con-
tained a proline-rich linker. These data suggested that, unlike
with repeated domains of the structured linkers, the increase in
separation between the Fab and Fc correlated predictably with
the number of cTPR repeats despite the presence of Gly4Ser
peptides flanking the N- and C-termini.
(Gly4ser)n linker series
In order to compare our structured linkers to the typical
unstructured Gly–Ser linkers commonly used in protein design
and engineering, we constructed, expressed and purified eight
IgG-(G4S)n variants. In contrast to the SEC profiles for the
structured linker constructs, there were only small differences in
Fig. 3. Overlay of size-exclusion chromatograms for IgGs containing flexible
and structured protein linkers. Structured linkers (L1–L8) exhibited larger
decreases in retention volume with respect to wild-type compared with
Gly4Ser linkers, which exhibited little to no decrease depending on the
number of repeats. Structured cTPR linkers also exhibited consistent decreases
in retention volume as a function of the number of repeats.
Fig. 4. Comparative analysis by DLS of the hydrodynamic radii (RH) of designed linkers in the context of the b12 IgG.
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elution volume for the IgGs including Gly4Ser linkers (L17–
L24). These differences often did not correlate with molecular
mass as IgG-GS9, the IgG with the largest linker, eluted at
approximately the same volume as wild-type IgG, which
eluted after some of the constructs with shorter linkers
(Fig. 3).
Unlike proline-rich linkers and rigid linkers consisting of
natural protein domains such as b2m, Gly4Ser linkers that did
not contain a potential N-linked glycosylation site did not
detectably increase the hydrodynamic radius of the IgG, sug-
gesting that these linkers did not provide increased separation
between the Fab and Fc domains (Fig. 4). These results were
consistent with the observation that Gly4Ser linkers did not
provide significant separation between the joined domains in
the context of other fusion proteins (Arai et al., 2001).
Measurements of IgG-GS9 from two preparations showed
only a slight difference in RH (0.1 nm), indicating that these
measurements were quite robust and relatively small differ-
ences in RH may be significant.
Optimized linkers are important for the construction of
multi-functional fusion proteins, in terms of both immunogen-
icity and conformational dynamics. Different linker composi-
tions can alter their effective length and rigidity. In this study,
we used SEC and DLS to characterize designed linkers in the
context of an IgG to determine whether these linkers could
increase the distance between the antigen-binding fragments.
We found that flexible Gly4Ser linkers did not increase the RH
of fused reagents, suggesting these linkers did not provide
increased separation between the Fab and Fc domains even
with up to nine Gly4Ser repeats, in agreement with previous
studies (Arai et al., 2001). By contrast, the structured helical
cTPR linkers provided consistent increases in RH and SEC
elution volume as a function of repeat number, indicating that
these repeats can be used to increase the separation distance
between two proteins or domains. Our other designed linkers,
including those containing naturally occurring proteins such
as b2m and ZAG, yielded increases in the observed RH by as
much as twice the RH of a naturally occurring IgG. The sys-
tematic characterization of the lengths and rigidity properties
of the structured protein linkers and a range of (Gly4Ser)n
linkers reported here provide a new set of tools to the available
linker repertoire for engineering fusion proteins.
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